{"transactions":[{"id":4706,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-04T21:00:31.000Z","date":"2026-09-02","kind":"grant","planned":false,"acquired":true,"shares":92400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in fifty equal monthly tranches beginning on the date of grant."}],"balance_after":92400,"derivative":{"exercise_price":1,"expiration_date":"2036-09-02","underlying":"Common Stock","underlying_shares":92400},"source":{"system":"sec-edgar","filing":"0001213900-26-097744","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390026097744/ownership.xml","form_type":"4"}},{"id":4705,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-04T21:00:31.000Z","date":"2026-09-02","kind":"grant","planned":false,"acquired":true,"shares":61600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). The RSUs vest as follows: 1/3 on the first anniversary of the date of grant, 1/3 on the second anniversary of the date of grant and 1/3 on the third anniversary of the date of grant."}],"balance_after":62357,"source":{"system":"sec-edgar","filing":"0001213900-26-097744","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390026097744/ownership.xml","form_type":"4"}},{"id":1183438,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T18:21:33.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":70311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":5,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":70311},"source":{"system":"sec-edgar","filing":"0001213900-25-028227","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390025028227/ownership.xml","form_type":"4"}},{"id":1183437,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T18:21:33.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":72156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":4.96,"expiration_date":"2032-07-01","underlying":"Common Stock","underlying_shares":72156},"source":{"system":"sec-edgar","filing":"0001213900-25-028227","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390025028227/ownership.xml","form_type":"4"}},{"id":1183436,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T18:21:33.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18351,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":6.07,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":18351},"source":{"system":"sec-edgar","filing":"0001213900-25-028227","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390025028227/ownership.xml","form_type":"4"}},{"id":1183435,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T18:21:33.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":9.55,"expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001213900-25-028227","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390025028227/ownership.xml","form_type":"4"}},{"id":1183434,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"tock Option (Right to Buy)","published_at":"2025-04-02T18:21:33.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":6.96,"expiration_date":"2029-07-12","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001213900-25-028227","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390025028227/ownership.xml","form_type":"4"}},{"id":1183433,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T18:21:33.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":23.49,"expiration_date":"2028-07-13","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001213900-25-028227","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390025028227/ownership.xml","form_type":"4"}},{"id":1183432,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T18:21:33.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":47.4,"expiration_date":"2027-03-28","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001213900-25-028227","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390025028227/ownership.xml","form_type":"4"}},{"id":1697949,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-29T17:18:40.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":70311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested."}],"balance_after":70311,"derivative":{"exercise_price":5,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":70311},"source":{"system":"sec-edgar","filing":"0001213900-23-100068","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390023100068/ownership.xml","form_type":"4"}},{"id":2217291,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-01T19:14:42.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":72156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price represents the closing price of the Company's common stock on July 1, 2022, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Company's 2019 Stock Plan, 2% of the options will vest each month from July 1, 2022 until fully vested."}],"balance_after":72156,"derivative":{"exercise_price":4.96,"expiration_date":"2032-07-01","underlying":"Common Stock","underlying_shares":72156},"source":{"system":"sec-edgar","filing":"0001213900-22-036871","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390022036871/ownership.xml","form_type":"4"}},{"id":2235923,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-10T16:46:27.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 9, 2022 and vests in full on June 9, 2023, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":807,"derivative":{"exercise_price":1.22,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":807},"source":{"system":"sec-edgar","filing":"0001104659-22-070176","document":"tm2218213-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000110465922070176/tm2218213-3_4seq1.xml","form_type":"4"}},{"id":2235922,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-10T16:46:27.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units that were granted on June 9, 2022, which will vest and be settled in common stock on June 9, 2023, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On April 26, 2022, the Issuer completed a one-for-forty reverse stock split of the Issuer's common stock. This amount has been adjusted to give effect to this reverse stock split."}],"balance_after":2241,"source":{"system":"sec-edgar","filing":"0001104659-22-070176","document":"tm2218213-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000110465922070176/tm2218213-3_4seq1.xml","form_type":"4"}},{"id":2579271,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-03T17:03:33.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":18351,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from September 1, 2021 until fully vested."}],"balance_after":18351,"derivative":{"exercise_price":6.07,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":18351},"source":{"system":"sec-edgar","filing":"0001213900-21-046685","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390021046685/ownership.xml","form_type":"4"}},{"id":2673980,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-06-10T19:10:08.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":29905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on June 8, 2021 and vests in full on June 8, 2022, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":29905,"derivative":{"exercise_price":1.53,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":29905},"source":{"system":"sec-edgar","filing":"0001104659-21-079617","document":"tm2119345-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000110465921079617/tm2119345-2_4seq1.xml","form_type":"4"}},{"id":2673979,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-10T19:10:08.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":24510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units that were granted on June 8, 2021, which will vest and be settled in common stock on June 8, 2022, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":62852,"source":{"system":"sec-edgar","filing":"0001104659-21-079617","document":"tm2119345-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000110465921079617/tm2119345-2_4seq1.xml","form_type":"4"}},{"id":3057313,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-14T17:03:43.000Z","date":"2020-08-12","kind":"grant","acquired":true,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested."}],"balance_after":8333,"derivative":{"exercise_price":9.55,"expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001213900-20-022319","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390020022319/ownership.xml","form_type":"4"}},{"id":3113428,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-11T17:21:39.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":22606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on June 9, 2020 and vests in full on June 9, 2021, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":22606,"derivative":{"exercise_price":2.8,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":22606},"source":{"system":"sec-edgar","filing":"0001104659-20-072487","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000110465920072487/a4.xml","form_type":"4"}},{"id":3113427,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-11T17:21:39.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":13393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units that were granted on June 9, 2020, which will vest and be settled in common stock on June 9, 2021, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":38342,"source":{"system":"sec-edgar","filing":"0001104659-20-072487","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000110465920072487/a4.xml","form_type":"4"}},{"id":3460785,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2019-07-16T16:58:08.000Z","date":"2019-07-12","kind":"grant","acquired":true,"shares":250000,"price":0.232,"value":58000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant."}],"balance_after":250000,"derivative":{"exercise_price":0.232,"expiration_date":"2029-07-12","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001213900-19-012871","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390019012871/ownership.xml","form_type":"4"}},{"id":3497271,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-07T16:32:09.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 6, 2019 and vests in full on June 6, 2020, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":75000,"derivative":{"exercise_price":1.03,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-19-034558","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000110465919034558/a4.xml","form_type":"4"}},{"id":3866396,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-07-17T17:10:43.000Z","date":"2018-07-13","kind":"grant","acquired":true,"shares":75000,"price":0.7829,"value":58717.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":0.7829,"expiration_date":"2028-07-13","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-18-009314","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390018009314/ownership.xml","form_type":"4"}},{"id":3900082,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-08T17:00:46.000Z","date":"2018-06-08","kind":"exercise","acquired":false,"shares":17949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 8, 2017, the Reporting Person was granted 17,949 restricted stock units, vesting in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attended at least 75% of the board meetings held during the year of board service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 8, 2017, the Reporting Person was granted 17,949 restricted stock units, vesting in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attended at least 75% of the board meetings held during the year of board service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17949},"source":{"system":"sec-edgar","filing":"0001104659-18-039215","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000110465918039215/a4.xml","form_type":"4"}},{"id":3900081,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-08T17:00:46.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on June 7, 2018 and vests in full on June 7, 2019, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":50000,"derivative":{"exercise_price":0.6,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-18-039215","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000110465918039215/a4.xml","form_type":"4"}},{"id":3900080,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T17:00:46.000Z","date":"2018-06-08","kind":"exercise","acquired":true,"shares":17949,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":24949,"source":{"system":"sec-edgar","filing":"0001104659-18-039215","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000110465918039215/a4.xml","form_type":"4"}},{"id":4023976,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-03-01T07:08:18.000Z","date":"2018-02-28","kind":"purchase","acquired":true,"shares":22730,"price":0.43,"value":9773.9,"ownership":{"direct":true},"balance_after":22730,"source":{"system":"sec-edgar","filing":"0001213900-18-002433","document":"f4022818shetty_actiniumpharm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000121390018002433/f4022818shetty_actiniumpharm.xml","form_type":"4"}},{"id":4282332,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-14T16:30:51.000Z","date":"2017-06-12","kind":"exercise","acquired":true,"shares":7000,"price":3.75,"value":26250.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001104659-17-039242","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000110465917039242/a4.xml","form_type":"4"}},{"id":4287075,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-09T17:03:00.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":17949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on June 8, 2017 and vest in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on June 8, 2017 and vest in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":17949,"derivative":{"underlying":"Common Stock","underlying_shares":17949},"source":{"system":"sec-edgar","filing":"0001104659-17-038461","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000110465917038461/a4.xml","form_type":"4"}},{"id":4287074,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":10177,"kind":"person","name":"Shetty Ajit","position":1,"cik":"0001667471","reported_name":"Shetty Ajit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-06-09T17:03:00.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 8, 2017 and vests in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":14000,"derivative":{"exercise_price":3.9,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-17-038461","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667471/000110465917038461/a4.xml","form_type":"4"}}]}